IQB-782 is utilized primarily in the field of medical research, particularly in the study of inflammatory diseases. Its application is focused on modulating specific pathways involved in inflammation, making it a valuable compound for developing new therapeutic strategies. Researchers are exploring its potential to treat conditions like rheumatoid arthritis and inflammatory bowel disease by targeting key mediators of the inflammatory response. Additionally, IQB-782 is being investigated for its role in enhancing the efficacy of existing treatments, potentially reducing the required dosage and minimizing side effects. Its unique mechanism of action also positions it as a promising candidate for further drug development in immunology and related fields.